<DOC>
	<DOCNO>NCT02279693</DOCNO>
	<brief_summary>This study evaluate dose receive prostate vivo dosimetry deliver image guide radiation therapy ( IGRT ) associate intensity modulate radiation therapy ( IMRT ) patient localized prostate cancer use two reposition technique : fiduciary marker soft tissue .</brief_summary>
	<brief_title>Evaluation Dose Received Prostate With Vivo Dosimetry Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques Localized Prostate Cancer</brief_title>
	<detailed_description>10 participant receive cone beam compute tomography ( CBCT ) repositioning , 10 receive kV image fiducial marker repositioning . The principal objective evaluate compare dose receive prostate use two reposition technique .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>male &gt; 18 year carcinoma prostate histologically confirm OMS 01 localize stage favorable , intermediate unfavorable group accord NCCN D'Amico classification patient must sign write informed consent form patient must affiliate Social Health Insurance . metastasis indication pelvic radiation anticoagulant therapy lateral bilateral hip replacement patient receive adult protective service Patient unable comply require medical followup geographic , social psychological reason</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Raypilot dosimetry</keyword>
	<keyword>CBCT ( cone beam compute tomography )</keyword>
</DOC>